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Abstract
 
Plasmodium falciparum
 
–infected erythrocytes roll on and/or adhere to CD36, intercellular adhe-
sion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and P-selectin under
shear conditions in vitro. However, the lack of an adequate animal model has made it difficult
to determine whether infected erythrocytes do indeed interact in vivo in microvessels. There-
fore, we made use of an established model of human skin grafted onto severe combined immu-
nodeficient (SCID) mice to directly visualize the human microvasculature by epifluorescence
intravital microscopy. In all grafts examined, infected erythrocytes were observed to roll and/or
adhere in not just postcapillary venules but also in arterioles. In contrast, occlusion of capillaries
by infected erythrocytes was noted only in approximately half of the experiments. Administra-
tion of an anti-CD36 antibody resulted in a rapid reduction of rolling and adhesion. More im-
portantly, already adherent cells quickly detached. The residual rolling after anti-CD36 treat-
ment was largely inhibited by an anti–ICAM-1 antibody. Anti–ICAM-1 alone reduced the
ability of infected erythrocytes to sustain rolling and subsequent adhesion. These findings pro-
vide conclusive evidence that infected erythrocytes interact within the human microvascula-
ture in vivo by a multistep adhesive cascade that mimics the process of leukocyte recruitment.
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Introduction
 
Malaria is by far the most important parasitic disease world-
wide and is second only to tuberculosis as an infectious
cause of death, particularly in rural Africa, where resources
to combat the infection are limited (1). Of the four species
of 
 
Plasmodium 
 
that infect humans, 
 
P
 
.
 
 falciparum
 
 accounts for
the majority of the infections and is also the most lethal.
Approximately two million individuals, mostly children,
die annually, partly from complications associated with un-
derperfusion of vital organs as a result of the sequestration
of infected erythrocytes in the microcirculation (2). Al-
though infected erythrocytes may be passively trapped in
microvessels due to a loss of deformability (3), it has also
been widely postulated that parasites actively adhere in
postcapillary venules to evade splenic clearance (4).
In vitro experiments would suggest that infected eryth-
rocytes can interact with various host proteins under both
static and flow conditions (for review see reference 5). For
example, application of hydrodynamic shear to infected
erythrocytes permits them to roll on CD36, intercellular
adhesion molecule (ICAM)-1, P-selectin, and vascular cell
adhesion molecule (VCAM)-1 (6–9). Subsequent adhesion
to CD36 has also been noted. Although these observations
imply that 
 
P. falciparum
 
 can induce the infected erythro-
cytes to roll and adhere, the experiments to date by our
laboratory and others have been designed to optimize the
conditions for cellular interactions. Shear forces are used at
levels at which interactions of infected erythrocytes with
adhesion molecules can be observed. In fact, the highest
shear stress used in vitro is thought to be at the very low
end of the shear forces in vivo (10). Moreover, adhesion
molecules are abundantly supplied in the form of immobi-
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lized receptor protein or expressed on transfected cells. The
lack of a suitable animal model for cytoadherence has
meant that the hypothesis that infected erythrocytes can ac-
tively adhere in the microcirculation to allow for propaga-
tion of the infection has never been tested directly.
In this study, we made use of a well established model of
human skin grafted onto SCID mice but extended the
model to directly visualize the human microvasculature us-
ing intravital microscopy. We provide direct evidence that
there is sufficient constitutive expression of CD36 and
ICAM-1 to allow
 
 
 
infected erythrocytes under physiologic
shear to roll on and adhere to not just human postcapillary
venules but also to human arteriolar vasculature. Moreover,
in some of the human skin grafts, capillary plugging was
not observed, yet active CD36-dependent adhesion was
evident, suggesting that in at least some cases active adhe-
sion may be the predominant mechanism that enables the
parasite to complete its life cycle without causing the de-
mise of the host. Most importantly, an anti-CD36 antibody
was able to reverse the firm adhesion of infected erythro-
cytes, raising the possibility that antiadhesive therapy could
be employed in severe falciparum malaria.
 
Materials and Methods
 
Parasite Culture.
 
Three clinical isolates of 
 
P
 
. 
 
falciparum
 
 ob-
tained from acutely infected patients admitted to the Hospital for
Tropical Diseases, Bangkok, Thailand were cultured as described
(7). The collection of patient specimens was approved by the
Ethics Committee of the Faculty of Tropical Medicine, Mahidol
University, Thailand. Cryopreserved parasites were thawed and
cultured for 24–36 h in RPMI medium (Life Technologies) sup-
plemented with 25 mM HEPES (Sigma-Aldrich), 100 U/ml pen-
icillin, and 100 
 
m
 
g/ml streptomycin (GIBCO BRL), 2 mM
glutamine (Sigma-Aldrich), and 10% AB serum from a normal
Thai donor. Infected erythrocytes were harvested for experiments
when they were at the late trophozoite/early schizont stage. The
parasitemias of the three isolates studied were between 5 and 7%.
In a previous study (7), these parasite isolates were shown to roll
on and adhere to CD36 transfectants, whereas the interaction
with ICAM-1 transfectants was mainly one of rolling, with 
 
,
 
5%
of the rolling cells eventually becoming adherent. These cytoad-
herent characteristics are well documented for infected erythro-
cytes obtained from the peripheral blood of infected patients (5).
 
Preparation of Human Skin Graft in SCID Mice.
 
CB-17 SCID/
beige mice (Harlan Canada) were grafted with split thickness hu-
man skin as described previously (11) under a protocol approved
by the Health Sciences Animal Welfare Committee and the
Health Research Ethics Board of the University of Alberta. In
brief, split thickness grafts from a single donor were prepared from
discarded human skin using a 0.1-inch dermatome. Recipient
mice were anesthetized using halothane. A 0.5 
 
3 
 
0.5-cm defect
was excised from the posterior thorax and covered with human
skin anchored using skin staples (US Surgical). The graft was al-
lowed to heal for 3 wk before the animal was used in the intravital
microscopy experiments.
 
Intravital Microscopy.
 
Animals were anesthetized with ket-
amine and xylazine, and body temperature was maintained at
physiological levels using a heating pad and rectal thermometer as
previously described (12). The procedure was approved by the
Animal Care Committee, University of Calgary. The jugular
vein was cannulated for administration of additional anesthetic,
boluses of infected erythrocytes, and antibodies. A midline dorsal
incision was made from the neck to the lower back without dis-
rupting the lateral dermal blood supply. The area of mouse skin
supporting the human graft was carefully separated from the un-
derlying tissue, with care taken not to disrupt the neovasculature
that supplied the base of the graft. The skin was reflected onto a
pedestal and secured with suture. The microvasculature within
the graft was exposed by gently dissecting the connective tissue
supporting the graft, causing minimal disruption to the graft
blood supply within this tissue. The graft was then moistened
with saline and covered with a coverslip. The preparation was
examined using an upright microscope (Optiphot-2; Nikon)
with a 20
 
3 
 
water immersion objective.
To identify human vessels, 100 
 
m
 
g of FITC-labeled 
 
Ulex euro-
paeus
 
 (Sigma-Aldrich) was injected intravenously immediately
before microscopic visualization. FITC-derived fluorescence was
visualized by epiillumination at 450–490 nm using a 520 nm
emission filter. Infected erythrocytes were labeled with rho-
damine 6G (1:10 of 0.05%, 5 min), and unbound rhodamine 6G
was removed by three washes in PBS. Rhodamine-labeled in-
fected erythrocytes were visualized by excitation at 510–560 nm
using a 590 nm emission filter. Pilot studies revealed that neither
 
U. europaeus 
 
nor rhodamine 6G at the doses used affected the
ability of infected erythrocytes to interact with endothelial cell
monolayers under flow conditions in vitro (Ho, M., unpublished
observations). The procedure did not label uninfected erythro-
cytes that were devoid of nuclear material. Each 200-
 
m
 
l bolus
contained infected erythrocytes at 
 
z
 
50% hematocrit and 5–7%
parasitemia. Images of the labeled infected erythrocytes and hu-
man microvessels were visualized using a silicon-intensified CCD
camera (C-2400-08; Hamamatsu Photonics) and recorded with a
VCR for playback analysis. The numbers of rolling and adherent
infected erythrocytes were determined off-line. Rolling of in-
fected erythrocytes was expressed as percentage flux fraction, de-
termined by counting the number of interacting infected eryth-
rocytes in an individual vessel and expressing this relative to the
total number of infected erythrocytes passing through the vessel
over the same period (determined by frame-by-frame analysis).
Infected erythrocytes that remained stationary on the vascular
wall for at least 30 s were defined as adherent.
In experiments involving inhibitory mAbs, 20–40 
 
m
 
g (
 
m
 
g/ml)
was injected as a bolus in a total volume of 100 
 
m
 
l of PBS after
baseline interactions had been recorded. The anti–human CD36
(OKM5; gift of Ortho Diagnostic, Raritan, NJ) and anti–human
ICAM-1 (84H10; R&D Systems) antibodies were found to be
effective at these concentrations under in vitro conditions (7–9).
The antibodies were allowed to circulate for 2–3 min before a
second bolus of infected erythrocytes was injected. The video-
tapes of the antibody experiments were analyzed without knowl-
edge of the effect of the antibodies on cytoadherence.
 
Immunohistochemical Staining.
 
At the time of intravital micros-
copy studies, skin was harvested from a representative animal in
the series and snap frozen in OCT. Sections were stained with
the antihuman mAbs anti–PECAM-1 (Becton Dickinson),
OKM5 (Ortho), 84H10 (R&D Systems), or irrelevant control
IgG (Cappel Laboratories) for expression of CD31, CD36, and
CD54, respectively. The biotin-conjugated secondary sheep
anti–mouse antibody (Jackson ImmunoResearch Laboratories,
Inc.) was developed using the ABC kit (Vector Laboratories) and
chromagen diaminobenzadine (Pierce Chemical Co.). Images
were obtained using a CCD digital camera (Nikon). 
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Online Supplemental Material.
 
The online supplemental data
comprises two video sequences taken from an experiment exam-
ining the interactions of 
 
P. falciparum
 
–infected erythrocytes in the
microvasculature of a human skin graft on a SCID mouse.
The video illustrates a vascular field within the human skin
graft, containing at least three separate microvessels that were la-
beled with FITC–
 
U. europaeus
 
. Infected erythrocytes were la-
beled with rhodamine 6G, and unbound stain was removed by
multiple washes. Uninfected erythrocytes were unlabeled. A bo-
lus of infected erythrocytes was injected into the circulation of
the mouse, and interactions with endothelial cells were examined
in the graft microvasculature over the following 10 min. Video 1
illustrates interactions of infected erythrocytes in an untreated hu-
man microvasculature. In several vessels, adherent infected eryth-
rocytes were apparent as cells stationary on the vascular wall. In
addition, infected erythrocytes can be observed rolling along the
walls of two vessels. Blood flow was maintained throughout this
area of the microvasculature. In Video 2, the graft microvascula-
ture was pretreated with mAbs against the human adhesion mole-
cules CD36 and ICAM-1. Despite many infected erythrocytes
flowing through the graft microvasculature (observed as streaks in
the centerline of blood flow), very few of them interacted with
the endothelium. These observations conclusively demonstrate a
role for CD36 and ICAM-1 in mediating the cytoadherence of
 
P
 
.
 
 falciparum
 
–infected erythrocytes in a human microvasculature
in vivo. Videos are available at http://www.jem.org.cgi/content/
full/192/8/1205/DC1.
 
Results
 
The adhesive interactions between infected erythrocytes
from clinical parasite isolates and a human microvascula-
ture were examined by epifluorescence intravital micros-
copy of human skin grafted onto SCID mice. The skin
graft retained the human microvascular bed of the superfi-
cial dermis, and the graft blood supply was restored by
spontaneous anastomosis of the mouse and human mi-
crovessels at the base of the graft (11). By fluorescently la-
beling the microvessels in vivo with the lectin 
 
U. europaeus
 
,
which specifically recognizes human endothelial cells of
vessels of all sizes (13), we were able to distinguish the spe-
cies origin of the microvessels in the fields of observation.
Fig. 1 a demonstrates that endothelial cells lining microves-
sels in the grafts were indeed of human origin, as FITC-
conjugated 
 
U. europaeus
 
 clearly labeled the graft vessels but
not adjacent murine skin (Fig. 1 b). However, the intensity
of labeling did differ and was in the order of arterioles 
 
.
 
capillaries 
 
. 
 
postcapillary venules. At the periphery of the
graft, some chimeric vessels were observed, lined by a mix-
ture of labeled (human) and unlabeled (murine) endothe-
lium (Fig. 1 c).
Rhodamine-labeled infected erythrocytes containing
trophozoites and schizonts were injected intravenously into
the animals. Infected erythrocytes continued to circulate in
significant numbers for 
 
z
 
10–15 min, after which parasite
accumulation was apparent in the spleen. In all eight grafts
examined, infected erythrocytes were observed to roll and/
or adhere in postcapillary venules of the human skin graft
(Fig. 2). Surprisingly, infected erythrocytes also interacted
with arterioles in 75% of grafts examined. The percentages
of infected erythrocytes that undergo rolling on and adhe-
sion to both sides of the microvasculature are shown in Fig.
3. In postcapillary venules, 
 
z
 
6% of the total number of
passing infected erythrocytes underwent rolling interac-
tions, whereas 10% rolled in arterioles. Adhesion of in-
fected erythrocytes was also observed. Significant adhesion
of infected erythrocytes was observed in postcapillary
venules in seven of eight grafts and in arterioles in one of
four grafts. Approximately two-thirds of the adherent in-
fected erythrocytes rolled for various distances before be-
coming arrested, while the rest appeared to bypass the roll-
ing event and adhered immediately after tethering. In
addition, occlusion of some capillaries by infected erythro-
cytes was observed after parasite injection in five of eight
grafts. Infected erythrocytes did not interact with murine
blood vessels in the surrounding skin, consistent with the
species specificity of the infection.
Figure 1. Identification of microvessels in vivo in human/SCID mouse
chimeras. (a) FITC–U. europaeus-labeled microvessels are detected in the
centre of the skin graft, indicating the presence of human endothelium.
A, arteriole; Cap, capillary; PCV, postcapillary venule. (b) Absence of U.
europaeus labeling in the microvasculature of adjacent murine skin. (c) A
chimeric microvessel lined by human (labeled) and murine (unlabeled)
endothelium at the periphery of the skin graft. 
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In the next series of experiments, the molecular mecha-
nisms by which infected erythrocytes interacted with the
human microvessels were identified. Human dermal mi-
crovascular endothelial cells have been shown to constitu-
 
tively express CD36 and ICAM-1 (14), the two major
molecules implicated by in vitro studies as mediating cy-
toadherence (15, 16). We showed that the microvascula-
ture in the human skin grafts retained expression of these
molecules as well as human platelet–endothelial cell adhe-
sion molecule (PECAM)-1 (Fig. 4, a–d). Intravital micros-
copy experiments showed that the addition of an anti-
CD36 mAb rapidly reduced rolling and adhesion of
infected erythrocytes in postcapillary venules (Fig. 5).
Moreover, already adherent infected erythrocytes quickly
detached after antibody administration. The residual rolling
of infected erythrocytes after anti-CD36 treatment was
largely inhibitable by anti–ICAM-1 treatment, resulting in
further reduction in the number of adherent cells. Treat-
ment of mice with anti–ICAM-1 alone also reduced rolling
and adhesion, although the parasite isolates tested were not
known to adhere to ICAM-1 under flow conditions in
vitro.
The effect of inhibitory antibodies on interactions of in-
fected erythrocytes in arterioles was also studied. Anti–
ICAM-1 reduced arteriolar rolling by 70%, but no effect
on adhesion was apparent (data not shown). Arteriolar in-
teractions were eliminated after treatment with a combina-
tion of anti-CD36 and anti–ICAM-1.
Figure 2. Interactions of infected erythrocytes and human endothelial
cells in the human skin graft model. Panels a–c illustrate the same vascular
field within the human skin graft. To aid identification, the vascular walls
are indicated by lines. Adherent or slowly moving (rolling) infected
erythrocytes are visible as discrete circular objects, while noninteracting
infected erythrocytes are observed as streaks in the centerline of blood
flow. Uninfected erythrocytes are unlabeled. Panels a and b are separated
by z3 s. Arrows indicate infected erythrocytes undergoing rolling inter-
actions with the endothelial surface of a postcapillary venule within the
graft. Over the 3-s time course, the rolling infected erythrocytes have
moved slowly along the vascular wall. At the same time, the patency of
the microcirculation is apparent as rapidly-moving, noninteracting in-
fected erythrocytes are observed throughout this period. Panel c illustrates
the same area of microvasculature after dual treatment with mAbs against
human CD36 and ICAM-1. Very few interacting infected erythrocytes
are observed despite many cells continuing to pass through the graft mi-
crovasculature. Videos illustrating the above points are explained in the
online supplemental material section and are available at http://
www.jem.org.cgi/content/full/192/8/1205/DC1.
Figure 3. Rates of rolling (a) and adhesion (b) of infected erythrocytes
in postcapillary venules and arterioles in human skin grafts. Data shown
are mean data from each graft, generated by averaging observations from
multiple vessels (four to seven venules, two to seven arterioles) in each
graft. IRBC, infected erythrocytes. 
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Figure 4. Immunohistochemical staining of sections from human skin grafts with mAbs specific to human endothelial antigens. (a) Control IgG; (b)
Anti–human CD31 (PECAM-1); (c) Anti–human CD36; (d) Anti–human CD54 (ICAM-1).
Figure 5. Effect of antibodies against human CD36 and ICAM-1 on rolling (a) and adhesion (b) of infected erythrocytes in postcapillary venules in hu-
man skin grafts. Data are shown as the mean 6 SEM of multiple observations before and after antibody administration in at least two skin grafts. IRBCs,
infected erythrocytes. 
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Discussion
 
It is now well established that leukocytes are initially
captured from the mainstream of blood flow by selectins
and roll along the endothelial surface. This rolling process
serves as a prerequisite for the subsequent arrest (adhesion)
of leukocytes on endothelial ICAM-1 (17). Despite the
hundreds of in vivo studies that repeatedly demonstrate the
multistep cascade of events for leukocytes in animal mod-
els, our data demonstrate for the first time that 
 
P. falci-
parum–
 
infected erythrocytes undergo similar interactions
under the unique physiological shear conditions and con-
figurations of adhesion molecule expression present in a
human microvasculature in vivo. Infected erythrocytes also
rolled and adhered but via a very different series of adhesive
mechanisms.
First, CD36, the scavenger receptor, was the dominant
adhesive molecule for rolling and adhesion. This molecule
does not support interactions with leukocytes (our unpub-
lished observations). Second, ICAM-1 supported infected
erythrocyte interactions with blood vessels under flow con-
ditions, but the interactions were of a rolling phenotype. As
leukocytes adhere but do not roll on ICAM-1 (10), 
 
P
 
.
 
 falci-
parum
 
 appears to have evolved the novel ability to roll on a
molecule designed to support human leukocyte adhesion.
Furthermore, ICAM-1 and CD36 acted synergistically in
the recruitment of infected erythrocytes, as inhibition of
rolling on ICAM-1 resulted in a reduction in the number
of adherent cells. Third, rolling and active adhesion of in-
fected erythrocytes occurred on both the arteriolar and
venular sides of the circulation, whereas leukocytes adhered
predominantly in venules and not at all in uninflamed mi-
crovessels. This finding suggests that adherent infected
erythrocytes can withstand very high shear rates. As two
very different cell systems, leukocytes and an intraerythro-
cytic pathogen, appear to make use of the rolling to adhe-
sion cascade, from an evolutionary standpoint it suggests
that the stepwise mechanism is likely the optimal strategy
for cellular recruitment under flow in blood vessels many
times the cell diameter.
The observation that infected erythrocytes interacted
with arteriolar endothelium was unexpected and was in ap-
parent contrast to all known in vivo evidence for cytoad-
herence from the histological examination of post mortem
tissues in which infected erythrocytes (but not uninfected
erythrocytes) are found in close apposition to venular en-
dothelium via electron-dense protrusions (18). It should be
stressed that the predominant adhesive interaction of in-
fected erythrocytes with arteriolar endothelium observed in
this study was rolling, which would not have been cap-
tured in tissue sections. Nevertheless, significant adhesion
to arterioles was observed in one of four skin grafts.
Whether this reflects lower shear stress in the murine com-
pared with human microcirculation remains to be deter-
mined.
The experimental model in this study likely reflects a
noninflammatory state. Indeed, our own work has previ-
ously revealed that the human/SCID mouse chimera has
no evidence of inflammation 21 d after transplant inasmuch
as no mouse leukocytes were noted in and around the hu-
man microvasculature (11). Our data suggest that CD36
and ICAM-1 by themselves are sufficient to support rolling
and adhesion of infected erythrocytes on noninflamed mi-
crovessels. However, it is well documented that TNF-
 
a
 
,
IL-1
 
b
 
, IL-6, and IFN-
 
g
 
 are all elevated during severe falci-
parum malaria (19–21), and it is likely that these cytokines
would induce the expression of adhesion molecules such as
P-selectin and VCAM-1 that have been shown to enhance
the adhesion of infected erythrocytes on human microvas-
cular endothelial cells in vitro (9).
In summary, the use of the human/SCID mouse model
has enabled us to directly visualize cell–cell interactions in a
human microvasculature. The results indicate that infected
erythrocytes from clinical parasite isolates roll and adhere to
both venules and arterioles in vivo, where the hydrody-
namic shear stress is significantly higher than that applied to
flow chambers in vitro. The human/SCID mouse chimera
thus provides an excellent model to further elucidate the
role of adhesion molecules in the pathogenesis of 
 
P. falci-
parum
 
 malaria and to evaluate potential therapeutic inter-
ventions that would disrupt the adhesive interactions of in-
fected erythrocytes with vascular endothelium in vivo.
Ultimately, this experimental model could be used to es-
tablish the importance of adhesion molecules in other dis-
ease states involving red blood cells, such as sickle cell
anemia, and leukocyte recruitment in a variety of inflam-
matory processes.
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